As of my last update in October 2023, TK-642, identified by the CAS number 2765183-10-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular structure, physical properties, and biological activity may not be widely documented in public databases, compounds like TK-642 are typically evaluated for their efficacy, safety, and pharmacokinetic properties in drug development. Generally, such substances may exhibit unique interactions with biological targets, which can lead to desired pharmacological effects. Researchers often investigate their solubility, stability, and reactivity under various conditions to understand their behavior in biological systems. For detailed and specific information regarding TK-642, including its synthesis, mechanism of action, and clinical data, consulting scientific literature or proprietary databases would be essential, as these sources provide the most current and comprehensive insights into the compound's characteristics and applications.

TK-642

2765183-10-4: As of my last update in October 2023, TK-642, identified by the CAS number 2765183-10-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular structure, physical properties, and biological activity may not be widely documented in public databases, compounds like TK-642 are typically evaluated for their efficacy, safety, and pharmacokinetic properties in drug development. Generally, such substances may exhibit unique interactions with biological targets, which can lead to desired pharmacological effects. Researchers often investigate their solubility, stability, and reactivity under various conditions to understand their behavior in biological systems. For detailed and specific information regarding TK-642, including its synthesis, mechanism of action, and clinical data, consulting scientific literature or proprietary databases would be essential, as these sources provide the most current and comprehensive insights into the compound's characteristics and applications.

<p>TK-642 is a potent and selective SHP2 inhibitor with oral activity, based on pyrazole and pyrazine structures (IC50 = 2.7 nmol/L). It effectively inhibits the proliferation of esophageal carcinoma cells and induces apoptosis, making it useful for studying esophageal cancer.</p>

CAS 2765183-10-4

TK-642

TK-642

Ref: TM-T88236